Total Clarity Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-144
Closed -$15K 999
2022
Q2
$15K Buy
+144
New +$17.1K 0.01% 599
2022
Q1
Sell
-148
Closed -$18K 941
2021
Q4
$18K Hold
148
0.01% 586
2021
Q3
$21K Buy
+148
New +$21.8K 0.01% 555
2021
Q2
Sell
-148
Closed -$23K 774
2021
Q1
$23K Buy
+148
New +$22.9K 0.01% 448
2020
Q1
Sell
-148
Closed -$22K 652
2019
Q4
$22K Buy
+148
New +$20.4K 0.02% 384

Other funds holding ZBH

Total Clarity Wealth Management's ZBH Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Zimmer Biomet (ZBH) in Q3 2022, closing a stake of 144 shares — an estimated $15K sold.

Total Clarity Wealth Management first reported a position in ZBH in Q4 2019 and held it in 5 quarters. The position peaked at $23K in Q1 2021. 919 funds tracked by Wall St. Rank hold ZBH as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Zimmer Biomet position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 144 Zimmer Biomet shares in Q3 2022, an estimated $15K.
  • Total Clarity Wealth Management first reported a position in Zimmer Biomet in Q4 2019 and held it in 5 quarters.
  • Total Clarity Wealth Management's Zimmer Biomet position peaked at $23K in Q1 2021.
  • 919 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.